Investment firm Black Forest completed the investment in ExploRNA Therapeutics, a biotech spin-off company of the University of Warsaw that develops groundbreaking mRNA modification technologies. Financial terms were not disclosed. The investment by Black Forest SICAV-SIF will allow ExploRNA Therapeutics to develop and implement an ambitious research programme focusing on the use of mRNA for therapeutic purposes and enhancing the company’s research potential.